Your browser doesn't support javascript.
loading
Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility.
Villarroya-Beltri, Carolina; Osorio, Ana; Torres-Ruiz, Raúl; Gómez-Sánchez, David; Trakala, Marianna; Sánchez-Belmonte, Agustin; Mercadillo, Fátima; Hurtado, Begoña; Pitarch, Borja; Hernández-Núñez, Almudena; Gómez-Caturla, Antonio; Rueda, Daniel; Perea, José; Rodríguez-Perales, Sandra; Malumbres, Marcos; Urioste, Miguel.
Affiliation
  • Villarroya-Beltri C; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid E-28029, Spain.
  • Osorio A; Familial Cancer Clinical Unit, CNIO, Madrid E-28029, Spain.
  • Torres-Ruiz R; Cytogenetic Unit, CNIO, Madrid E-28029, Spain.
  • Gómez-Sánchez D; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.
  • Trakala M; Advanced Therapies Unit, Hematopoietic Innovative Therapies Division, Instituto de Investigación Sanitaria Fundacion Jimenez Díaz (IIS-FJD, UAM), Madrid E-28040, Spain.
  • Sánchez-Belmonte A; Hereditary Cancer Laboratory, Doce de Octubre University Hospital, i+12 Research Institute, Madrid, Spain.
  • Mercadillo F; Clinical and Translational Lung Cancer Research Unit, i+12 Research Institute and Biomedical Research Networking Center in Oncology (CIBERONC), Madrid, Spain.
  • Hurtado B; Koch Institute, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
  • Pitarch B; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid E-28029, Spain.
  • Hernández-Núñez A; Familial Cancer Clinical Unit, CNIO, Madrid E-28029, Spain.
  • Gómez-Caturla A; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid E-28029, Spain.
  • Rueda D; Cell Division and Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid E-28029, Spain.
  • Perea J; Dermatology Service, Fuenlabrada University Hospital, Fuenlabrada, Madrid, Spain.
  • Rodríguez-Perales S; Digestive Department, University Hospital of Guadalajara, Guadalajara, Spain.
  • Malumbres M; Hereditary Cancer Laboratory, Doce de Octubre University Hospital, i+12 Research Institute, Madrid, Spain.
  • Urioste M; Molecular Medicine Unit, Department of Medicine, Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.
Sci Adv ; 8(44): eabq5914, 2022 Nov 04.
Article in En | MEDLINE | ID: mdl-36322655

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Sci Adv Year: 2022 Document type: Article Affiliation country: España

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Sci Adv Year: 2022 Document type: Article Affiliation country: España